AMY KZYONSEK: Open Payments
NPI 1982758298 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 45 payments from 11 companies in 2025. Trend: 2023 $1,071 · 2024 $930 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $224 |
| Neurocrine BioSciences, Inc. | 10 | $182 |
| E.R. Squibb & Sons, L.L.C. | 10 | $147 |
| Janssen Pharmaceuticals, Inc | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Braeburn Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: ABILIFY MAINTENA, INGREZZA, COBENFY, INVEGA SUSTENNA, CAPLYTA, FANAPT, UZEDY, BRIXADI.
Industry payments across MI — which companies pay providers there.
